Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, Par Value $0.001
-
Shares outstanding
-
94.7M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
83.2M
-
Shares change
-
+3.71M
-
Total reported value, excl. options
-
$746M
-
Value change
-
+$32.1M
-
Put/Call ratio
-
0.02
-
Number of buys
-
48
-
Number of sells
-
-33
-
Price
-
$8.97
Significant Holders of Enfusion Inc. - Common Stock, Par Value $0.001 (ENFN) as of Q3 2023
99 filings reported holding ENFN - Enfusion Inc. - Common Stock, Par Value $0.001 as of Q3 2023.
Enfusion Inc. - Common Stock, Par Value $0.001 (ENFN) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83.2M shares
of 94.7M outstanding shares and own 87.84% of the company stock.
Largest 10 shareholders include FTV Management Company, L.P. (32.4M shares), ICONIQ Capital, LLC (14M shares), BROWN CAPITAL MANAGEMENT LLC (11.1M shares), HHLR ADVISORS, LTD. (4.98M shares), VANGUARD GROUP INC (3.49M shares), Ararat Capital Management LP (2.37M shares), BlackRock Inc. (2.33M shares), 12 West Capital Management LP (1.9M shares), JANUS HENDERSON GROUP PLC (1.63M shares), and NEW YORK STATE COMMON RETIREMENT FUND (1.62M shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.